Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Immunosuppressor FK506 Increases Endoglin and Activin Receptor-Like Kinase 1 Expression and Modulates Transforming Growth Factor-β1 Signaling in Endothelial Cells

Virginia Albiñana, Francisco Sanz-Rodríguez, Lucía Recio-Poveda, Carmelo Bernabéu and Luisa M. Botella
Molecular Pharmacology May 2011, 79 (5) 833-843; DOI: https://doi.org/10.1124/mol.110.067447
Virginia Albiñana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francisco Sanz-Rodríguez
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lucía Recio-Poveda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carmelo Bernabéu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luisa M. Botella
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 79 no. 5 833-843
DOI 
https://doi.org/10.1124/mol.110.067447
PubMed 
21310938

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received July 12, 2010
  • Accepted February 10, 2011
  • Published online April 19, 2011.

Article Versions

  • Earlier version (February 10, 2011 - 09:26).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2011 The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Virginia Albiñana,
  2. Francisco Sanz-Rodríguez,
  3. Lucía Recio-Poveda,
  4. Carmelo Bernabéu and
  5. Luisa M. Botella
  1. Centro de Investigaciones Biológicas (CIB), Consejo Superior de Investigaciones Científicas (CSIC) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) (V.A., L.R.P., C.B., L.M.B.); and Departamento de Biología Celular, Facultad de Biología, Universidad Autónoma de Madrid (F.S.R.), Madrid, Spain
  1. Address correspondence to:
    Dr. Luisa María Botella, Centro de Investigaciones Biológicas, CSIC, C/Ramiro de Maeztu, 9 Madrid 28040, Spain. E-mail: cibluisa{at}cib.csic.es
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: March 2011 to January 2023

AbstractFullPdf
Feb 20111620240
Mar 2011990136
Apr 20112802191
May 20112733151
Jun 2011812044
Jul 2011571628
Aug 2011581516
Sep 2011622221
Oct 2011441516
Nov 201135717
Dec 201126814
Jan 201235712
Feb 2012321021
Mar 201265725
Apr 20122517
May 2012283134
Jun 2012191520
Jul 2012253528
Aug 2012292416
Sep 201223515
Oct 2012376042
Nov 2012262023
Dec 2012161619
Jan 2013392921
Feb 2013263224
Mar 2013241513
Apr 2013251218
May 2013211519
Jun 2013111410
Jul 2013201611
Aug 201383417
Sep 2013122120
Oct 2013252913
Nov 2013111814
Dec 2013151718
Jan 2014117416
Feb 2014234214
Mar 201484216
Apr 2014182118
May 2014113743
Jun 2014162411
Jul 201411209
Aug 201416279
Sep 2014193918
Oct 2014121113
Nov 2014162124
Dec 2014132323
Jan 2015143119
Feb 20158178
Mar 2015163310
Apr 2015173613
May 2015294534
Jun 2015213821
Jul 2015104219
Aug 2015192023
Sep 2015151313
Oct 201593215
Nov 201561612
Dec 20153157
Jan 2016212918
Feb 20169229
Mar 2016111814
Apr 201611126
May 2016231410
Jun 2016112018
Jul 201671132
Aug 2016174326
Sep 201691514
Oct 20166327
Nov 20160308
Dec 201613312
Jan 20170246
Feb 20171202
Mar 20170255
Apr 20172239
May 20171286
Jun 20170297
Jul 20173428
Aug 201715111
Sep 201722510
Oct 20170264
Nov 201712218
Dec 20172379
Jan 201813111
Feb 20182508
Mar 201855515
Apr 20181419
May 20181509
Jun 20182543
Jul 20181261
Aug 20181215
Sep 20181231
Oct 201803210
Nov 20180248
Dec 20182894
Jan 20192067
Feb 20193003
Mar 20195002
Apr 20192505
May 20193303
Jun 20191915
Jul 20193513
Aug 20192713
Sep 20191403
Oct 20192044
Nov 20193702
Dec 20193452
Jan 20202642
Feb 20202022
Mar 20202211
Apr 20203240
May 20202522
Jun 20202517
Jul 20201100
Aug 2020851
Sep 20201601
Oct 2020712
Nov 20201302
Dec 20202632
Jan 20212131
Feb 20213914
Mar 20215562
Apr 20214600
May 20215534
Jun 20211564
Jul 20212412
Aug 20213022
Sep 20211710
Oct 20211810
Nov 20212533
Dec 20213111
Jan 20224235
Feb 20222242
Mar 20221231
Apr 20221032
May 20223922
Jun 20222011
Jul 20221533
Aug 20221521
Sep 20221111
Oct 20222345
Nov 20223134
Dec 20221900
Jan 20232511

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 79 (5)
Molecular Pharmacology
Vol. 79, Issue 5
1 May 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Immunosuppressor FK506 Increases Endoglin and Activin Receptor-Like Kinase 1 Expression and Modulates Transforming Growth Factor-β1 Signaling in Endothelial Cells
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Immunosuppressor FK506 Increases Endoglin and Activin Receptor-Like Kinase 1 Expression and Modulates Transforming Growth Factor-β1 Signaling in Endothelial Cells

Virginia Albiñana, Francisco Sanz-Rodríguez, Lucía Recio-Poveda, Carmelo Bernabéu and Luisa M. Botella
Molecular Pharmacology May 1, 2011, 79 (5) 833-843; DOI: https://doi.org/10.1124/mol.110.067447

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Immunosuppressor FK506 Increases Endoglin and Activin Receptor-Like Kinase 1 Expression and Modulates Transforming Growth Factor-β1 Signaling in Endothelial Cells

Virginia Albiñana, Francisco Sanz-Rodríguez, Lucía Recio-Poveda, Carmelo Bernabéu and Luisa M. Botella
Molecular Pharmacology May 1, 2011, 79 (5) 833-843; DOI: https://doi.org/10.1124/mol.110.067447
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Fatty acid amide hydrolase in cisplatin nephrotoxicity
  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
  • Benzbromarone relaxes airway smooth muscle via BK activation
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics